Evidence map›Paper›PMID 27171554›Full record

ArticlePloS one2016

Nocturnal Fanning Suppresses Downy Mildew Epidemics in Sweet Basil.

Yigal Cohen, Yariv Ben-Naim

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yigal CohenThe Mina &Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat-Gan, Israel.
Yariv Ben-NaimThe Mina &Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat-Gan, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Downy mildew is currently the most serious disease of sweet basil around the world. The oomycete causal agent Peronospora belbahrii requires ≥ 4h free leaf moisture for infection and ≥7.5h of water-saturated atmosphere (relative humidity RH≥95%) at night for sporulation. We show here that continued nocturnal fanning (wind speed of 0.4-1.5 m/s) from 8pm to 8am dramatically suppressed downy mildew development. In three experiments conducted during 2015, percent infected leaves in regular (non-fanned) net-houses reached a mean of 89.9, 94.3 and 96.0% compared to1.2, 1.7 and 0.5% in adjacent fanned net-houses, respectively. Nocturnal fanning reduced the number of hours per night with RH≥95% thus shortened the dew periods below the threshold required for infection or sporulation. In experiments A, B and C, the number of nights with ≥4h of RH≥95% was 28, 10 and 17 in the non-fanned net-houses compared to 5, 0 and 5 in the fanned net-houses, respectively. In the third experiment leaf wetness sensors were installed. Dew formation was strongly suppressed in the fanned net-house as compared to the non-fanned net-house. Healthy potted plants became infected and sporulated a week later if placed one night in the non-fanned house whereas healthy plants placed during that night in the fanned house remained healthy. Infected potted basil plants sporulated heavily after one night of incubation in the non-fanned house whereas almost no sporulation occurred in similar plants incubated that night in the fanned house. The data suggest that nocturnal fanning is highly effective in suppressing downy mildew epidemics in sweet basil. Fanning prevented the within-canopy RH from reaching saturation, reduced dew deposition on the leaves, and hence prevented both infection and sporulation of P. belbahrii.

Indexed as

Air MovementsDarknessCrops, AgriculturalEpidemicsHumidityOcimum basilicumPeronosporaPlant DiseasesPlant LeavesSporesTemperature

Identifiers

PMID27171554
PMCPMC4865134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.